<DOC>
	<DOCNO>NCT00155558</DOCNO>
	<brief_summary>To determine maximum tolerate dose dose limit toxicity 5-FU leucovorin novel 48-hour infusion schedule , collect toxicity profile different dose level 5-FU/LV 48-hour infusion .</brief_summary>
	<brief_title>A Phase I Trial HDFL48 Recurrent Metastatic Colorectal Cancers</brief_title>
	<detailed_description>Colorectal cancer one major Taiwan.It cause 3128 death 1999 , represent No.3 cancer killer male female population Taiwan . Recently , evidence accumulate weekly , 24-hour infusion high-dose 5-FU may improve response rate survival time compare 5-FU bolus regiment . In randomized multicenter trial metastatic colorectal cancer , Kohne et al report overall response rate 44 % median survival time 16 month use weekly-times-six schedule infusional 5-FU ( 2600mg/m2 24-hours infusion ) . In another randomize study advance colorectal cancer , de Gramont et al report significantly well outcome patient treat similar schedule combine `` bolus plus infusional '' 5-FU compare `` bolus '' 5-FU . These result suggest 24-or 48-hour infusion high-dose 5-FU effective conventional bolus schedule .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Pathologically confirm recurrent metastatic colorectal adenocarcinoma Patients indicate 5FU ( 1stline recurrence/metastasis ) , OR fail 5FU , treatment schedule At least one bidimensionally measurable lesion ( ) Previous C/T , R/T &gt; = 4 week KPS &gt; 50 % Age &gt; = 18 year Fasting TG &gt; 70 mg/dL ( within 7 day ) WBC &gt; = 3,000/uL ANC &gt; = 1,500/uL Plt &gt; = 75,000/uL Cre &lt; = 1.5 mg/dL Proteinuria &lt; 1+ Normal Tbil AST/ ALT &lt; = 3.5fold ULN Concomitant anticancer therapy radiotherapy CNS metastasis Pregnant woman Patients second malignancy Symptomatic heart disease ( significant arrhythmia , CHF MI within 3 month entry ) Active infection exist Extensive liver disease liver cirrhosis Patients refuse PortA catheter implantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2000</verification_date>
	<keyword>Colorectal Cancer , Maximum tolerate dose</keyword>
</DOC>